2021/04/07
MVC Announces Pre-Print Publication in MedRxiv Showing the Interim Analysis Result of First-in-Human Trial of a Recombinant SARS-CoV-2 Spike Protein (S-2P) Vaccine with Adjuvant of Aluminum Hydroxide and CpG 1018
see more
2021/03/23
MVC Announces Pre-Print Publication in MedRxiv Evaluating the neutralizing ability of a CpG-adjuvanted S-2P subunit vaccine against SARS-CoV-2 Variants of Concern
see more